相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer
Karina H. Gravgaard et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer
James S. Duncan et al.
CELL (2012)
Combined PI3K/mTOR and MEK Inhibition Provides Broad Antitumor Activity in Faithful Murine Cancer Models
Patrick J. Roberts et al.
CLINICAL CANCER RESEARCH (2012)
Genome-Wide miRNA Expression Profiling Identifies miR-9-3 and miR-193a as Targets for DNA Methylation in Non-Small Cell Lung Cancers
Gerwin Heller et al.
CLINICAL CANCER RESEARCH (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Progression of RAS-Mutant Leukemia during RAF Inhibitor Treatment
Margaret K. Callahan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo
E. Leucci et al.
ONCOGENE (2012)
Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas
Jacob Minor et al.
ORAL ONCOLOGY (2012)
AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity
Sarat Chandarlapaty et al.
CANCER CELL (2011)
CpG island methylation of microRNAs is associated with tumor size and recurrence of non-small-cell lung cancer
Kentaro Kitano et al.
CANCER SCIENCE (2011)
GSK1120212 (JTP-74057) Is an Inhibitor of MEK Activity and Activation with Favorable Pharmacokinetic Properties for Sustained In Vivo Pathway Inhibition
Aidan G. Gilmartin et al.
CLINICAL CANCER RESEARCH (2011)
MicroRNA-9 Reveals Regional Diversity of Neural Progenitors along the Anterior-Posterior Axis
Boyan Bonev et al.
DEVELOPMENTAL CELL (2011)
Aberrant hypermethylation of miR-9 genes in gastric cancer
Kuo-Wang Tsai et al.
EPIGENETICS (2011)
MicroRNA-9 Regulates Neurogenesis in Mouse Telencephalon by Targeting Multiple Transcription Factors
Mikihito Shibata et al.
JOURNAL OF NEUROSCIENCE (2011)
MicroRNA-mediated conversion of human fibroblasts to neurons
Andrew S. Yoo et al.
NATURE (2011)
Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas
Lars Fischer et al.
NEURO-ONCOLOGY (2011)
Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes
S. Tabaries et al.
ONCOGENE (2011)
MicroRNA-9 Functional evolution of a conserved small regulatory RNA
Yeliz Yuva-Aydemir et al.
RNA BIOLOGY (2011)
DNA methylation of tumor suppressor miRNA genes: a lesson from the miR-34 family
Kwan Yeung Wong et al.
EPIGENOMICS (2011)
beta 1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib
Catherine Huang et al.
BREAST CANCER RESEARCH (2011)
MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy
Andrea L. Kasinski et al.
NATURE REVIEWS CANCER (2011)
miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells
Haibo Zhou et al.
BLOOD (2010)
Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K
Jessie Villanueva et al.
CANCER CELL (2010)
Dual Functional Monoclonal Antibody PF-04605412 Targets Integrin α5β1 and Elicits Potent Antibody-Dependent Cellular Cytotoxicity
Gang Li et al.
CANCER RESEARCH (2010)
Metastatic Growth from Dormant Cells Induced by a Col-I-Enriched Fibrotic Environment
Dalit Barkan et al.
CANCER RESEARCH (2010)
Three-Dimensional Overlay Culture Models of Human Breast Cancer Reveal a Critical Sensitivity to Mitogen-Activated Protein Kinase Kinase Inhibitors
Quanwen Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Cory M. Johannessen et al.
NATURE (2010)
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
Li Ma et al.
NATURE CELL BIOLOGY (2010)
A minicircuitry involving REST and CREB controls miR-9-2 expression during human neuronal differentiation
Pietro Laneve et al.
NUCLEIC ACIDS RESEARCH (2010)
Molecular Stratification of Triple-Negative Breast Cancers
Charles M. Perou
ONCOLOGIST (2010)
Alteration of MicroRNAs Regulated by c-Myc in Burkitt Lymphoma
Anna Onnis et al.
PLOS ONE (2010)
Kinase requirements in human cells: V. Synthetic lethal interactions between p53 and the protein kinases SGK2 and PAK3
Amy Baldwin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Aleix Prat et al.
BREAST CANCER RESEARCH (2010)
Preclinical Evaluation of the Novel Small-Molecule Integrin α5β1 Inhibitor JSM6427 in Monkey and Rabbit Models of Choroidal Neovascularization
Grit Zahn et al.
ARCHIVES OF OPHTHALMOLOGY (2009)
Xenoestrogen-Induced Epigenetic Repression of microRNA-9-3 in Breast Epithelial Cells
Pei-Yin Hsu et al.
CANCER RESEARCH (2009)
A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene
Ji Luo et al.
CELL (2009)
Most mammalian mRNAs are conserved targets of microRNAs
Robin C. Friedman et al.
GENOME RESEARCH (2009)
The Plasticity of Oncogene Addiction: Implications for Targeted Therapies Directed to Receptor Tyrosine Kinases
Vinochani Pillay et al.
NEOPLASIA (2009)
Volociximab, a Chimeric Monoclonal Antibody that Specifically Binds α5β1 Integrin: A Phase I, Pharmacokinetic, and Biological Correlative Study
Alejandro D. Ricart et al.
CLINICAL CANCER RESEARCH (2008)
The Bifunctional microRNA miR-9/miR-9*Regulates REST and CoREST and Is Downregulated in Huntington's Disease
Amy N. Packer et al.
JOURNAL OF NEUROSCIENCE (2008)
Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer
U. Lehmann et al.
JOURNAL OF PATHOLOGY (2008)
MicroRNA-9 directs late organizer activity of the midbrain-hindbrain boundary
Christoph Leucht et al.
NATURE NEUROSCIENCE (2008)
miRBase: tools for microRNA genomics
Sam Griffiths-Jones et al.
NUCLEIC ACIDS RESEARCH (2008)
The microRNA.org resource: targets and expression
Doron Betel et al.
NUCLEIC ACIDS RESEARCH (2008)
The integrin - Growth factor receptor duet
Naved Alam et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Design and synthesis of a new class of selective integrin α5β1 antagonists
Roland Stragies et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Biological characterization of ARRY-142886 (AZD6244), a potent, highly selective mitogen-activated protein kinase kinase 1/2 inhibitor
Tammie C. Yeh et al.
CLINICAL CANCER RESEARCH (2007)
Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines
Antoinette Hollestelle et al.
MOLECULAR CANCER RESEARCH (2007)
Novel c-MYC target genes mediate differential effects on cell proliferation and migration
David Cappellen et al.
EMBO REPORTS (2007)
A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo
Parisa Khalili et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Combinatorial microRNA target predictions
A Krek et al.
NATURE GENETICS (2005)
Inhibition of integrin α5β1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice
O Stoeltzing et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Induction of β3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway
D Woods et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
R Sears et al.
GENES & DEVELOPMENT (2000)
分享论文
